Details:

Personal Author:
Mofenson, Lynne M.
Corporate Authors:
Centers for Disease Control and Prevention (U.S.) ; Infectious Diseases Society of America ; National Center for HIV, STD and TB Prevention (U.S.) ; National Institutes of Health (U.S.)
Centers for Disease Control and Prevention (U.S.) ; Infectious Diseases Society of America ; National Center for HIV, STD and TB Prevention (U.S.) ; National Institutes of Health (U.S.) Less -
Description:
"In 2001, CDC, the National Institutes of Health, and the Infectious Diseases Society of America convened a working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opportunistic infections to serve as a companion to the Guidelines for Prevention of Opportunistic Infections Among HIV-Infected Persons. In recognition of unique considerations related to HIV infection among infants, children, and adolescents, a separate pediatric working group was established. Because HIV-infected women coinfected with opportunistic pathogens might be more likely to transmit these infections to their infants than women without HIV infection, guidelines for treating opportunistic pathogens among children should consider treatment of congentially acquired infections among both HIV-exposed but uninfected children and those with HIV infection. In addition, the natural history of opportunistic infections among HIV-infected children might differ from that among adults. Compared with opportunistic infections among HIV-infected adults, which are often caused by reactivation of pathogens acquired before HIV infection when host immunity was intact, opportunistic infections among children often reflect primary acquisition of the pathogen and, among children with perinatal HIV infection, infection acquired after HIV infection has been established and begun to compromise an already immature immune system. Laboratory diagnosis of opportunistic infections can be more difficult with children. Finally, treatment recommendations should consider differences between adults and children in terms of drug pharmacokinetics, dosing, formulations, administration, and toxicities. This report focuses on treatment of opportunistic infections that are common in HIV-exposed and infected infants, children, and adolescents in the United States." - p. 1

Published also as: Clinical infectious diseases ; v. 40, suppl. 1.

Includes bibliographical references (p. 52-63).


Content Notes:
prepared by Lynne M. Mofenson ... [et al.].

"The material in this report originated in the Office of the Director, National Center for HIV, STD and TB Prevention, Janet L. Collins, M.D., Acting Director. " - p. 1


Subject:
[+]
Adolescent AIDS-Related Opportunistic Infections Anti-Infective Agents Child Child, Preschool Diagnosis Epidemiology Periodical Issue Therapeutic Use Therapy AIDS-Related Opportunistic Infections/Diagnosis AIDS-Related Opportunistic Infections/Epidemiology AIDS-Related Opportunistic Infections/Therapy Anti-Infective Agents/Therapeutic Use
Series:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-14 ; Clinical infectious diseases ; v. 40, suppl. 1
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-14 ; Clinical infectious diseases ; v. 40, suppl. 1 Less -
Pubmed ID:
15577752
Document Type:
Journal Issue
Genre:
Practice Guideline
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:70659375e8948dd528a6317312f2bdc96c136e0931712f72bf5d7a8c3e29a0e3
Download URL:
https://stacks.cdc.gov/view/cdc/6776/cdc_6776_DS1.pdf
File Type:

Supporting Files

• No Additional Files

More +